uniQure's IPO

uniQure raised a round of funding on February 05, 2014. Investors include Public.

uniQure is delivering on the promise of gene therapy, single treatments with potentially curative results. The company has developed a modular platform to rapidly bring new disease modifying therapies…

Articles about uniQure's IPO: